The General Assembly of the European project MINIGRAPH was hosted by the Fraunhofer Institute for Reliability and Microintegration in Berlin on September 28th and 29th, 2023, marking the end of the first year of the project. During the assembly participants showcased the advancements of the project aiming at addressing critical challenges in treating brain disorders using novel neuroelectronic therapies.

While these novel neuroelectronic therapies offer immense potential in treating a wide range of brain disorders, their adoption is currently hindered by technological and clinical obstacles. MINIGRAPH, a groundbreaking initiative funded by the EIC Pathfinder programme of the European Commission, endeavours to overcome these challenges. Leveraging the unique properties of graphene, the project focuses on developing an innovative neuroelectronic therapy and implantation procedure. This pioneering approach integrates closed-loop brain modulation capabilities, flexible electronics, and high-density graphene interfaces, promising significant advancements in spatial resolution, signal-to-noise ratio, biocompatibility, and adaptability to brain tissue.

The MINIGRAPH project is a testament to European collaboration, uniting top academic research centres and innovative SMEs. Partners such as the Catalan Institute of Nanoscience and Nanotechnology (ICN2), INBRAIN Neuroelectronics, IMEC, Fraunhofer, Institute of Robotics and Intelligent Systems – The Multi-Scale Robotics Lab at ETH Zurich, Nanoflex Robotics, Leiden University Medical Center and Czech Advanced Technology and Research Institute of Palacký University Olomouc bring together diverse expertise crucial for the successful development and eventual market launch of MINIGRAPH’s groundbreaking technologies.